LINDSAY KLOER: Open Payments
NPI 1720272875 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 96 payments from 15 companies in 2025. Trend: 2023 $1,653 · 2024 $1,592 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $370 |
| Janssen Biotech, Inc. | 14 | $242 |
| UCB, Inc. | 10 | $176 |
| GENZYME CORPORATION | 6 | $174 |
| LEO Pharma Inc. | 9 | $160 |
| Lilly USA, LLC | 10 | $157 |
| Organogenesis Inc. | 8 | $156 |
| Novartis Pharmaceuticals Corporation | 6 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Amgen Inc. | 3 | $57 |
Products named: TREMFYA, RINVOQ, Bimzelx, DUPIXENT, TALTZ, ADBRY, SKYRIZI, NOVACHOR.
Industry payments across MO — which companies pay providers there.
